Effect of gastric bypass versus diet on cardiovascular risk factors

Annals of Surgery

Volumn 259, Issue 4, 2014, Pages 694-699

  Raffaelli, Marco ^a   Guidone, Caterina ^a   Callari, Cosimo ^a   Iaconelli, Amerigo ^a   Bellantone, Rocco ^a   Mingrone, Geltrude ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Apolipoprotein A4; cardiovascular risk; gastric bypass; HDL cholesterol; hypocaloric diet

Indexed keywords

APOLIPOPROTEIN A4; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FAT MASS; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; LOW CALORY DIET; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ROUX EN Y GASTRIC BYPASS; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; APOLIPOPROTEINS A; BIOLOGICAL MARKERS; BLOOD PRESSURE; CALORIC RESTRICTION; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OBESITY, MORBID; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT REDUCTION PROGRAMS;

EID: 84895925364     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31829d6989     Document Type: Article

References (43)

1. Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: A systematic review. Heart. 2012;98:1763-1777.
2. Kim S, Richards WO. Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass. Ann Surg. 2010;251:1049-1055.
3. Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51:2405-2412.
4. Bots ML, Breslau PJ, Briet E, et al. Cardiovascular determinants of carotid artery disease: The Rotterdam Elderly Study. Hypertension. 1992;19:717-720.
5. Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:1705-1711.
6. ChapmanMJ, Assmann G, Fruchart JC, et al. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: The role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin. 2004;20:1253-1268.
7. Gordon DJ, Rifkind BM. High-density lipoprotein-The clinical implications of recent studies. N Engl J Med. 1989;321:1311-1316.
8. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: A Mendelian randomisation study. Lancet. 2012;380:572-580.
9. Singh V, Sharma R, Kumar A, et al. Low high-density lipoprotein cholesterol: Current status and future strategies for management. Vasc Health Risk Manag. 2010;6:979-996.
10. Beisiegel U, Utermann G. An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur J Biochem. 1979;93:601-608.
11. Fukagawa K, Gou HM, Wolf R, et al. Circadian rhythm of serum and lymph apolipoprotein AIV in ad libitum-fed and fasted rats. Am J Physiol Regul Integr Comp Physiol. 1994;267:R1385-R1390.
12. Green PH, Glickman RM, Saudek CD, et al. Human intestinal lipoproteins. Studies in chyluric subjects. J Clin Invest. 1979;64:233-242.
13. Doi T, Liu M, Seeley RJ, et al. Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding. Am J Physiol Regul Integr Comp Physiol. 2001;281:R753-R759.
14. Hayashi H, Nutting DF, Fujimoto K, et al. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J Lipid Res. 1990;31:1613-1625.
15. Kalogeris TJ, Fukagawa K, Tsuchiya T, et al. Intestinal synthesis and lymphatic secretion of apolipoprotein A-IV after cessation of duodenal fat infusion: Mediation by bile. Biochim Biophys Acta. 1999;1436:451-466.
16. Ghiselli G, Crump WL, III, Gotto AM, Jr. Binding of apoA-IV-phospholipid complexes to plasma membranes of rat liver. Biochem Biophys Res Commun. 1986;139:122-128.
17. Qi L, Liu S, Rifai N, et al. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis. 2007;192:204-210.
18. Wong WM, Hawe E, Li LK, et al. Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res. 2003;92:969-975.
19. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
20. Mari A, Pacini G, Murphy E, et al. A model-basedmethod for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24:539-548.
21. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest. 2006;116:607-614.
22. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585.
23. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patientswith diabetes. N Engl JMed. 2012;366:1567-1576.
24. Salinari S, Bertuzzi A, Guidone C, et al. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg. 2013;257:462-468.
25. Geloneze B, Geloneze SR,Chaim E, et al.Metabolic surgery for non-obese type 2 diabetes: Incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg. 2012;256:72-78.
26. Jørgensen NB, Jacobsen SH, Dirksen C, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab. 2012;303:E122-E131.
27. Gleysteen JJ, Barboriak JJ, Sasse EA. Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr. 1990;51:774-778.
28. Sjostrom L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group, Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
29. Adams TD, Gress RE, Smith SC, et al. Long-termmortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
30. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695-704.
31. Bisgaier CL, SachdevOP, Lee ES, et al. Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. J Lipid Res. 1987;28:693-703.
32. Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 2012;35:2613-2617.
33. DeLamatre JG, Hoffmeier CA, Lacko AG, et al. Distribution of apolipoprotein A-IV between the lipoprotein and lipoprotein-free fractions of rat plasma: Possible role of lecithin:cholesterol acyltransferase. J Lipid Res. 1983;24:1578-1585.
34. Stein O, Stein Y, Lefevre M, et al. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta. 1986;878:7-13.
35. Duverger N, Tremp G, Caillaud JM, et al. Protection against atherogenesis in mice mediated by human apolipoprotein AIV. Science. 1996;273:966-968.
36. Fournier N, Atger V, Paul JL, et al. Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol. 2000;20:1283-1292.
37. Aalto-Setala K, Bisgaier CL, Ho A, et al. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J Clin Invest. 1994;93:1776-1786.
38. Lo CM, Xu M, Yang Q, et al. Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and Apo AIV concentration. Am J Physiol Regul Integr Comp Physiol. 2009;296:R43-R50.
39. Qin X, Tso P. The role of apolipoprotein AIV on the control of food intake. Curr Drug Targets. 2005;6:145-151.
40. Tadross JA, le Roux CW. The mechanisms ofweight loss after bariatric surgery. Int J Obes. 2009;33:S28-S32.
41. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
42. Lu C, Zhu W, Shen CL, et al. Green tea polyphenols reduce body weight in rats by modulating obesity-related genes. PLoS One. 2012;7:e38332. doi: 10.1371/journal.pone.0038332.
43. Bueter M, Lowenstein C, Olbers T, et al. Gastric bypass increases energy expenditure in rats. Gastroenterology. 2010;138:1845-1853.